STREATHAM HIGH PRACTICE
2-8 GRACEFIELD GARDENS, STREATHAM, LONDON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 9 | 10 | 90.0% | |
| HF 4 | 2011 | 16 | 19 | 84.2% | |
| HF 4 | 2012 | 14 | 15 | 93.3% | |
| HF 4 | 2013 | 14 | 14 | 100.0% | |
| HF004 | 2014 | 8 | 8 | 100.0% | |
| HF004 | 2015 | 11 | 11 | 100.0% | |
| HF004 | 2016 | 8 | 8 | 100.0% | |
| HF004 | 2017 | 15 | 16 | 93.8% | |
| HF004 | 2018 | 16 | 16 | 100.0% | |
| HF004 | 2019 | 16 | 16 | 100.0% | |
| HF004 | 2020 | 28 | 29 | 96.6% | |
| HF006 | 2021 | 30 | 34 | 88.2% | |
| HF006 | 2022 | 36 | 37 | 97.3% | |
| HF006 | 2023 | 38 | 39 | 97.4% |
